Search Orphan Drug Designations and Approvals
-
Generic Name: | [(S)-1-(L-valyl)-N_((S)-1-phenyl-2-(pyridin-2-yl)ethyl)pyrrolidine-2-carboxamide fumarate] |
---|---|
Date Designated: | 06/22/2017 |
Orphan Designation: | Treatment of Rett Syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Biohaven Pharmaceutical Holding Company, Ltd. 215 Church Street New Haven, Connecticut 06511 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-